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Abstract 
Meador-Woodruff, James Ii., Alfred Mansour, Olivier Civelli and Stanley J. Watson: Distribu- 
tion of D2 Dopamine Receptor mRNA in the Primate Brain. Prog. Neuro-Psychopharmacol. 6 Biol. 
Psychiat. 1991, 15 (6):885-893. - 
1. The distribution of the messenger RNA (mRNA) encoding the Dgdopamine receptor has been 
mapped in the monkey brain by in situ hybridization. 
2. Using [35S]-labelled riboprobes corresponding to the region of the D2 dopamine receptor 
spanning the third cytosolic loop and the sixth and seventh transmembrane domains, 
specific hybridization was observed in a number of neural structures. 
3. High levels of mRNA expression were observad in the caudate, putamen, and claustrum. 
Significant amounts were also identified in the hippocampus, lateral geniculate nucleus, 
much of the cortex, amygdala, pons, and thalamus. High levels of this mRNA were also 
visualized in the substantia nigra, likely reflecting autoreceptor synthesis. 
4. While the distribution of D2 dopamine receptor mRNA was similar between the monkey and 
previously published maps in the rat, several differences were noted. 
5. These results demonstrate the feasibility of visualizing this mRNA in the primate brain, 
and suggest that a similar analysis of human postmortem brain material may be possible. 
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Introduction 
Dopamine is a key brain neurotransmitter, associated with a number of neuropsychiatric 
disturbances, especially schizophrenia and Parkinson disease. Several of the dopamine 
receptors have been recently cloned (Bunzow et al 1988. Grandy et al 1989. Dearry et al 1990, 
Monsma et al 1990, Sunahara et al 1990, Zhou et al 1990) and investigations related to the 
distribution and regulation of the messenger RNA (mRNA) encoding these receptors are now 
possible, The cloning of a rat D2 receptor was originally reported by Bunzow and coworkers 
(1988). using the hamster 82-adrenergic receptor gene as a probe. A number of groups have 
more recently reported that there are at least two distinct forms of D2 receptor mRNA 
(Dal Toso et al 1989, Giros et al 1989, Monsma et al 1989, Selbie et al 1989), due to alter- 
nate splicing of this gene during transcription. The original clone that was reported by 
Bunzow et al (1988) is 87 bases (29 amino acids) shorter than the second form that was sub- 
sequently identified; the difference between these two forms is due to the inclusion or 
exclusion of exon 5 in the final transcripts. 
We and others have previously reported the distribution in the rat brain of the mRNA encod- 
ing the D2.receptor using in situ hybridization (Meador-Woodruff et al 1989, Mengod et al 
1989, Najlerahim et al 1989, Weiner and Brann 1989. Mansour et al 1990). In this report, we 
extend our previous work to include the mapping of the distribution of total D2 receptor 
mRNA in the monkey brain. These results demonstrate the feasibility of visualizing this 
mRNA in the primate brain, thus lay the framework for subsequent investigations of the 
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nature of D2 receptor gene expression in postmortem brains derived from Individuals that had 
suffered from a variety of neuropsychiatric disorders. 
Methods 
Animals 
Brains of old-world monkeys (macaca mulatta) were removed following ketamine anesthesia and 
cut Into l-2 cm coronal slabs, which were frozen in isopentane (-3OoC) for 120 sec. Frozen 
tissue was cryostat-sectioned (20 urn) and thaw-mounted onto microscope slides. These sections 
were maintained at -800C until the time of hybridization. 
Experimental Procedure 
The determination of total D2 receptor mRNA was made using [35S]-labelled riboprobes synthe- 
sized from a Sac I-B& 11 fragment of a rat D2 receptor cDNA (Bunzow et al 1988). This probe 
is a 495 base region corresponding to the third cytosollc loop and the sixth and seventh 
transmembrane domains of the rat D2 receptor. This region was selected as the greatest degree 
of dissimilarity between the catecholamine receptors occurs in the third cytosollc loop, thus 
providing a greater degree of probe specificity. This probe is 3’ to the exon encoding the 29 
amino acids which distinguish D2h from D28 mRNAs, hence recognizes both forma, or total D2 
receptor mRNA. The in situ hybridization protocol that we previausly described (Meador- 
Woodruff et al 1989. Mansour et al 1990) waa used, except hybridization took place in 50% 
formamide buffer, and the final post-hybridization wash (60 min) was at 550C in 0.5X SSC (300 
mM NaC1/30 mM sodium citrate, pH 7.2). 
Results 
D2 receptor mRNA was visualized in a number of structures, including traditional dopamine 
terminal fields associated with both motor and limbic circuits, as well as in dopamine- 
containing cell bodies. A high labelling density was observed in components of the baaal 
ganglia: the caudate, putamen, and claustrum all had high concentrations of D2 receptor mRNA, 
although the globus pallidua had very low levels (Fig 1). A number of llmbic structures were 
identified as having moderate levels of thia message, including much of the cortex (both 
superficial and deep layers), the lateral septum, and the amygdala (Figs 1, 2, and 4). The 
hippocampus manifested distinct patterning (Fig 4): the highest density of labelling was seen 
in granular cell layer of the dentate gyrua , with moderate signal in the pyramidal cell layer 
of CA2, CA3, and CA4, with faint labelling in CAI. In addition, faint labelling was 
appreciated in the stratum lacunosum-moleculare. A number of other structures were identified 
as containing D2 receptor mRNA including the lateral geniculate nucleus and the pons, while a 
faint homogeneoua labelling could be appreciated in the thalamus (Figs 2 and 4). 
D2 receptor mRNA was also visualized in the midbrain dopamine-containing cell group, the 
pars compacta of the aubstantia nlgra (Fig 3). This likely represents autoreceptor-encoding 
mRNA, which is similar to the finding of thia mRNA in the midbrain dopamine-containing nuclei 
of the rat. 
The specificity of this labelling was confirmed by several standard control experiments 
commonly used in in situ hybridization studies. Adjacent sections were probed with the 
“sense” atrand riboprobe generated from the same plasmld construct used to generalte the 
“antiaense” probe used for the Images presented in theses studies, as we have previously 
described in our studies in the rat brain (Meador-Woodruff et al 1989, Mansour et al 1990). 
Additionally, aome sections were treated with RNaae A prior to hybridization with the “anti- 
sense” riboprobe. RNaae pretreatment eliminated all of the labelllng seen In the figures 
contained in this report. “Sense”-strand hybridization resulted in some faint labelling in 
some regions of the cortex and In the hippocampus, but was much less than the signal seen with 
the “antisense” probe, suggesting that most of the labelling seen with the “antisense” probe 
waa specific for D2 receptor mRNA. Northern gel analysis waa performed with tissues corre- 
sponding to the monkey sections shown in this report, resulting in a single, uniformly-sized 
mRNA band In the caudate, hippocampus, and substantia nlgra (data not shown). 
Finally, atrong labelling waa observed In the cerebellum which was eliminated with RNaae 
pretreatment, but the intensity of labelling was approximately equal between the “sense” and 
“antlaense’‘-strand probes, and no mRNA band was appreciated on a Northern gel, suggesting that 
this cerebellar labelling was in large part artifactual. 
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Discussion 
These findings demonstrate that D2 receptor mRNA is distributed in both traditional dopamin- 
oceptive as well as DA-containing regions of the primate brain, and is strikingly similar to 
the distribution of this mRNA in the rodent brain (Meador-Woodruff et al 1990, Mengod et al 
1989, Najlerahim et al 1989, Weiner and Brann 1989, Mansour et al 1990). Several differences 
in the distribution of this mRNA between rat and the monkey were noted, however, especially 
the lamination of message in the cortex and in the hippocampus. The vast majority of D2 
receptor mRNA in the rat cortex is in superficial layers (Mansour et al 1990), whereas in the 
monkey it appears in both superficial and deep layers. In the rat hippocampus, this mRNA is 
equally distributed throughout the. pyramidal cells of CAl-CA4 and in the granular cells of the 
dentate gyrus (Meador-Woodruff et al 1989, Mansour et al 1990). In the monkey, the relative 
density of labelling is considerably more variable between these structures; in addition, 
Fig.1. Distribution of D2 dopamine receptor mRNA in the monkey forebrain. Note 
prominent labelling in the caudate (C) and putamen (P), as well as in many regions 
of cortex (insular cortex, Ci; cingulate cortex, Cc; piriform dortex, Cp). There 
is also some labelling observable in the lateral septum (LS), amygdala (Amy), and 
claustrum (CL). There is minimal labelling in the globus pallidus (GP). 
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D2 receptor mRNA could also be appreciated in the stratum locunosum-moleculare, an area 
associated with D2 receptor binding sites but not mRNA localization in the rat. The 
functional significance of these differences remain to be elucidated. 
The localization of total D2 receptor mRNA in the monkey, as well as in the rodent, 
parallels what would be predicted based on pat autoradiographic and immunohistochemical 
research identifying dopaminergic circuits in the brain (Boyson et al 1986, Bouthenet et al 
1987, Charuchinda et al 1987, Richfield et al 1987, Dawson et al 1988, Wamsley et al 1989). 
A number of studies in the rat (Meador-Woodruff et al 1989, Mengod et al 1989, Najlerahim et 
al 1989, Weiner and Brann 1989, Mansour et al 1990) have demonstrated D2 receptor mRNA in 
every region traditionally implicated as a DA receptive field, reflecting postsynaptic recep- 
tor synthesis. These studies provide anatomical confirmation of the dopaminoceptive nature 
of these various limbic and striatal regions. 
The finding of D2 receptor mRNA in some DA-containing cell groups in the rat brain (i.e., 
Fig 2. Distribution of D2 dopamine receptor mRNA in the monkey brain at the level of the 
thalamus (Th). The tails of the caudate (C) and putamen (P) are visible and labelled. The 
substantia nigra (SN) is prominent in this section; the labelling observed in the SN probably 
reflects D2 autoreceptor sysnthesis. Labelling is also seen in much of the cortex, as well 
as in the lateral geniculate nucleus (LGN), hippocampus (H) and dentate gyrus (DG), and pans. 
Faint labelling is seen in the thalamus. 
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the substantia nigra) by a number of groups (Meador-Woodruff et al 1989, Mengod et al 1989, 
Weiner and Brann 1989, Mansour et al 1990) suggests that D2 receptors may have an auto- 
receptor function. The appearance of D2 receptor mRNA in the monkey substantia nigra 
compliments these previous findings in the rat brain. These findings are consistent with 
previous studies indicating that the midbrain DA autoreceptor is D2 in nature (Reisine et al 
1979, Stoof et al 1982, White and Wang 1983, Brown et al 1985). 
In addition to this extension of our understanding of the brain DA systems, these studies 
have also demonstrated the feasibility of examining the expression of the D2 receptor gene in 
an anatomical context in the primate brain, thus setting the stage for postmortem investiga- 
tions in the human. Messenger RNA levels tend to be quite stable in the brain following 
death, requiring hours to days to change appreciably in concentration (Birnberg et al 1983). 
Thus, mRNA levels tend not to be altered rapidly at the time of death, unlike neurotrans- 
mitters, which may be acutely released, causing changes in receptor occupancy. In addition, 
Fig 3. High power view of D2 receptor mRNA at the level of the substantia nigra (SN). In 
addition to strong labelling in the SN, faint labelling can be appreciated in the oculomotor 
nucleus (OMN, upper left corner). 
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the concentration of a specific mRNA in the brain likely reflects the cumulative history 
of the particular system rather than the more recent terminal events, thus providing a more 
integrated view of the regulation of a given system. Accordingly, the measurement of mRNA 
levels in postmortem human brain may be advantageous in the study of certain neuropsychiatric 
illnesses. 
The present data demonstrates the feasibility of studying D2 receptor mRNA in postmortem 
monkey brain, and hopefully reflects the level of information available from the study of the 
human brain. The study of the expression of the D2 receptor gene in human brain should now 
be possible in a number of neuropsychiatric conditions, especially schizophrenia. 
Fig 4. D2 dopamine receptor mRNA in the hippocampus. Note striking labelling in the der 
gyrus (DG), as well as distinct lamination of labelling in the hippocampus as well as in 
cortex. The lateral geniculate nucleus (LGN) is also visible 
state 
the 
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Conclusion 
Dopamine D2receptor mRNA was visualized in a number of areas of the monkey brain, including 
both motor and limbic terminal fields, as well as in the substantia nigra. It is likely 
that both postsynaptic receptors as well as autoreceptors are being visualized. The distri- 
bution of this mRNA is,strikingly similar to what we and others have observed and reported 
in the rat brain. This report demonstrates the feasibility of visualizing dopamine D2 
receptor mRNA in the primate brain. and will hopefully set the stage for the subsequent 
investigation of the expression of the D2 receptor gene in human brain in a variety of 
neuropsychiatric diseases. 
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